Todd Thomson is listed as a director on 5 SEC Form D filings by 1 issuer between Oct 2022 and Jul 2025: ACTUATE THERAPEUTICS, INC. (Fort Worth, TX — pharmaceuticals — 2022–2025; $21.9M reported sold to 95 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
The issuer belongs to the sponsor group Bios (35 issuers, $212.4M reported sold, 2013–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Bios has 35 companies on file and $212.4M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Todd Thomson and found 10 differences: Form D filed 19 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.